Ameriprise Financial Inc Pacific Biosciences Of California, Inc. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $3.67 Million - $10 Million	-1,042,745 Reduced 97.08%	31,410 $117,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $5.8 Million - $10.1 Million	971,764 Added 949.07%	1,074,155 $10.5 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $172,402 - $291,805	20,948 Added 25.72%	102,391 $854,000
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $13.9 Million - $19.6 Million	-1,391,749 Reduced 94.47%	81,443 $1.08 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $12.02 $1.13 Million - $1.71 Million	-142,435 Reduced 8.82%	1,473,192 $17.1 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $8.96 Million - $17.7 Million	1,579,844 Added 4415.07%	1,615,627 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $140,627 - $306,660	35,783 New	35,783 $208,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $115,168 - $298,809	-28,649 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $20.9 Million - $51.7 Million	-2,474,038 Reduced 98.86%	28,649 $260,000
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $5.4 Million - $8.43 Million	280,209 Added 12.61%	2,502,687 $51.2 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $57,451 - $80,931	2,311 Added 0.1%	2,222,478 $56.8 Million
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $10.5 Million - $17 Million	471,044 Added 26.93%	2,220,167 $77.6 Million
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $15.3 Million - $29.7 Million	-581,377 Reduced 24.95%	1,749,123 $58.3 Million
Q4 2020 Feb 12, 2021	BUY	$10.5 - $28.5 $22.5 Million - $61.2 Million	2,146,953 Added 1169.7%	2,330,500 $60.5 Million
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $3.21 Million - $8.77 Million	-888,531 Reduced 82.88%	183,547 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$2.65 - $4.03 $1.67 Million - $2.54 Million	629,869 Added 142.44%	1,072,078 $3.7 Million
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $1.36 Million - $3.04 Million	-577,395 Reduced 56.63%	442,209 $1.35 Million
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $3 Million - $3.63 Million	651,911 Added 177.3%	1,019,604 $5.24 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $305,572 - $377,219	61,237 Added 19.98%	367,693 $1.9 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $99,266 - $124,250	16,768 Added 5.79%	306,456 $1.85 Million
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $1.18 Million - $1.28 Million	173,366 Added 149.04%	289,688 $2.09 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $412,286 - $808,040	103,330 Added 795.34%	116,322 $862,000
Q3 2018 Nov 14, 2018	SELL	$3.52 - $5.55 $10,560 - $16,650	-3,000 Reduced 18.76%	12,992 $76,000
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $42 - $78	20 Added 0.13%	15,992 $56,000
Q3 2017 Nov 07, 2017	BUY	$3.2 - $5.57 $51,110 - $88,964	15,972	15,972 $84,000

Others Institutions Holding PACB

# of Institutions

259

Shares Held

256M

Call Options Held

3.05M

Put Options Held

1.71M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

36M
Shares

$55.5 Million
0.58% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$36.4 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$36 Million
8.16% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

21.3M
Shares

$32.9 Million
0.68% of portfolio
Softbank Group Corp Minato Ku Tokyo, M0

20.5M
Shares

$31.5 Million
0.17% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $346M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account